surf break copy_edited.jpg

Materna Medical Raises $10 Million in Series A2 Funding in Women's Health

Materna Medical (Materna), a clinical-stage medical device company, has announced the completion of a $10 million Series A2 financing round. The round was led by Wavemaker Three-Sixty Health (Wavemaker 360) with new investors including Kimera Limited, Women's Venture Capital Fund, Golden Seeds, Black Capital, Shatter Fund, and Astia Angels. Key existing investors also joined the syndicate including Band of Angels, Texas Halo Fund, and Houston Angel Network.


Recent Posts

See All

Emerging Opportunities: Real-World Evidence

Key takeaways • Real-world evidence (RWE) has the potential to be useful across the entire healthcare ecosystem, including for clinical trials, care provision, determining treatment outcomes, and post

Invitae to Acquire Ciitizens

Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Ciitizen, a patient-centric consumer health tech company. Backed by a16z